Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Grazia Vitale
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
University of Udine,
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Azienda sanitaria universitaria Friuli Centrale
ORCID:
0000-0003-2331-5315
Observed ORCID:
0000-0003-2331-5315
OpenAlex ID:
A5107884137
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
2019
·
Debora Basile
, Annamaria Parnofiello
, et al.
·
Journal of Cachexia Sarcopenia and Muscle
·
90
PDF
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression
2017
·
Debora Basile
, Marika Cinausero
, et al.
·
Cancer Treatment Reviews
·
87
Sarcopenia in gastric cancer: when the loss costs too much
2017
·
Elena Ongaro
, Vanessa Buoro
, et al.
·
Gastric Cancer
·
79
PDF
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for a Cost-Effective and Dynamic Biomarker
2019
·
Giacomo Pelizzari
, Debora Basile
, et al.
·
Cancers
·
70
PDF
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva
2020
·
Michele Bartoletti
, Roberta Mazzeo
, et al.
·
International Journal of Gynecological Cancer
·
36
PDF
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis
2020
·
Lorenzo Gerratana
, Debora Basile
, et al.
·
Scientific Reports
·
28
PDF
The Role of BRAF-Targeted Therapy for Advanced Melanoma in the Immunotherapy Era
2019
·
Vito Vanella
, Lucia Festino
, et al.
·
Current Oncology Reports
·
28
Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study
2018
·
Claudia Bozza
, Lorenzo Gerratana
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
15
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study
2025
·
Mario Mandalà
, Teresa Amaral
, et al.
·
European Journal of Cancer
·
12
PDF
Determinants of Last-line Treatment in Metastatic Breast Cancer
2017
·
Marika Cinausero
, Lorenzo Gerratana
, et al.
·
Clinical Breast Cancer
·
12
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma
2025
·
Domenico Mallardo
, Mario Fordellone
, et al.
·
Journal for ImmunoTherapy of Cancer
·
10
PDF
Neuroblastoma rat sarcoma mutated melanoma: That’s what we got so far
2019
·
Elisa Bertoli
, Marco Giavarra
, et al.
·
Pigment Cell & Melanoma Research
·
9
PDF
“To Anticipate”: Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers
2020
·
Mattia Garutti
, Silvia Buriolla
, et al.
·
Cancers
·
7
PDF
Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase
2023
·
Giacomo Pelizzari
, Elisa Bertoli
, et al.
·
Melanoma Research
·
4
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study
2020
·
Marta Bonotto
, Debora Basile
, et al.
·
Future Oncology
·
4
Prognostic role of alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) in metastatic breast cancer (MBC) patients: First clues for cost-effective biomarkers.
2018
·
Giacomo Pelizzari
, Lorenzo Gerratana
, et al.
·
Journal of Clinical Oncology
·
4
Combination or sequence of vemurafenib, cobimetinib, and atezolizumab in high-risk, resectable melanoma (NEO-TIM): Primary results.
2024
·
Paolo Antonio Ascierto
, Pietro Quaglino
, et al.
·
Journal of Clinical Oncology
·
3
Electronic patient-reported outcomes, fever management, and symptom prediction among patients with BRAF V600 mutant stage III–IV melanoma: The Kaiku Health platform
2024
·
Peter Mohr
, Paolo Ascierto
, et al.
·
EJC Skin Cancer
·
3
PDF
Serum thymidine kinase activity (TKa) as a potential biomarker in the sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma (SECOMBIT) trial.
2025
·
Hildur Helgadottir
, Mariaelena Capone
, et al.
·
Journal of Clinical Oncology
·
2
Discontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases
2026
·
Mario Mandalà
, Monica F Chen
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
Efficacy of anti-PD-1 rechallenge in metastatic melanoma: A retrospective analysis.
2025
·
Ester Simeone
, Domenico Mallardo
, et al.
·
Journal of Clinical Oncology
·
1
Association of clinical factors and biological subtypes with different Ca15-3 levels in metastatic breast cancer.
2018
·
Marta Bonotto
, Lorenzo Gerratana
, et al.
·
Journal of Clinical Oncology
·
1
Explainable machine learning predictive models for treatment response after SBRT in melanoma brain metastases
2026
·
Savino Cilla
, Rossella Di Franco
, et al.
·
Journal of Neuro-Oncology
Immune Checkpoint Inhibitor Data in Metastatic Melanoma with Pre-Existing Autoimmune Disease: A Real World Experience
2026
·
Maria Grazia Vitale
, Domenico Mallardo
, et al.
·
International Journal of Molecular Sciences
Lights and shadows of time-of-day administration of immune checkpoint inhibitors in solid tumors: a comprehensive review with exploratory analyses
2026
·
Bianca Arianna Facchini
, Agostina Lagodin D’Amato
, et al.
·
Journal of Translational Medicine
Show more works
View as search
Works count:
34
Citation count:
506
H-index:
10
I10-index:
11
Year
Topic
Type